Gilead Dives As HHS Reportedly Mulls Cutting HIV Prevention FundingInvestors Business Daily • 03/19/25
Buy 3 U.S. Giants Flying High Year to Date Defying Severe VolatilityZacks Investment Research • 03/19/25
Gilead Stock Falls on Report Trump Administration Wants to Cut HIV-Prevention FundingBarrons • 03/19/25
GILD Stock Trading Close to Its 52-Week High: Should You Buy or Sell?Zacks Investment Research • 03/17/25
Follow the Leader: 2 Biopharma Stocks Showing Relative Strength in 2025Zacks Investment Research • 03/13/25
Gilead Presents New HIV Treatment and Cure Research Data at CROI 2025, Including an Investigational Long-Acting, Twice-Yearly Therapy OptionBusiness Wire • 03/12/25
Gilead Sciences, Inc. (GILD) Leerink Partners Global Healthcare Conference - (Transcript)Seeking Alpha • 03/11/25
First Clinical Data for Gilead's Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The LancetBusiness Wire • 03/11/25
Buy 5 Non-Tech High-Flying Nasdaq Stocks Amid Index's Recent BloodbathZacks Investment Research • 03/11/25
The Top Nasdaq-100 Stock in 2025 Has Nothing to Do With Artificial Intelligence (AI)The Motley Fool • 03/11/25
S&P 500 ETF's Worst Week Since September: 5 Top Stocks Poised to RiseZacks Investment Research • 03/10/25
Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 03/10/25
3 Healthcare Stocks With Strong EPS Growth Potential to Buy in 2025Zacks Investment Research • 03/07/25
Gilead Sciences, Inc. (GILD) Hits Fresh High: Is There Still Room to Run?Zacks Investment Research • 03/05/25
Gilead Sciences, Inc. (GILD) TD Cowen 45th Annual Healthcare Conference (Transcript)Seeking Alpha • 03/04/25
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025Invezz • 03/04/25
Do You Own 15 Stocks Morningstar Calls The Top 'Wealth Destroyers?'Investors Business Daily • 03/03/25